These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10956330)

  • 1. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol.
    Gunasekara L; Schürch S; Schoel WM; Nag K; Leonenko Z; Haufs M; Amrein M
    Biochim Biophys Acta; 2005 Oct; 1737(1):27-35. PubMed ID: 16216549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids.
    Cimato A; Hoyos Obando A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2016 Nov; 233():33-40. PubMed ID: 27476933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the compression ratio on properties of lung surfactant (bovine lipid extract surfactant) films.
    Lu JY; Distefano J; Philips K; Chen P; Neumann AW
    Respir Physiol; 1999 Jan; 115(1):55-71. PubMed ID: 10344415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
    Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
    Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
    Cockshutt AM; Absolom DR; Possmayer F
    Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bilirubin on surface tension properties of lung surfactant.
    Amato M; Schürch S; Grunder R; Bachofen H; Burri PH
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F191-6. PubMed ID: 8976686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inhibitory effects of oxygen radicals and calf serum protein on surfactant activity.
    Lee MM; Green FH; Schürch S; Cheng S; Bjarnason SG; Leonard S; Wallace W; Possmayer F; Vallyathan V
    Mol Cell Biochem; 2004 Apr; 259(1-2):15-22. PubMed ID: 15124903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants.
    Putz G; Goerke J; Taeusch HW; Clements JA
    J Appl Physiol (1985); 1994 Apr; 76(4):1425-31. PubMed ID: 8045815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constrained sessile drop as a new configuration to measure low surface tension in lung surfactant systems.
    Yu LM; Lu JJ; Chan YW; Ng A; Zhang L; Hoorfar M; Policova Z; Grundke K; Neumann AW
    J Appl Physiol (1985); 2004 Aug; 97(2):704-15. PubMed ID: 15064296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Component-specific surface and physiological activity in bovine-derived lung surfactants.
    Notter RH; Wang Z; Egan EA; Holm BA
    Chem Phys Lipids; 2002 Jan; 114(1):21-34. PubMed ID: 11841823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of humidity on the stability of lung surfactant films adsorbed at air-water interfaces.
    Zuo YY; Acosta E; Policova Z; Cox PN; Hair ML; Neumann AW
    Biochim Biophys Acta; 2006 Oct; 1758(10):1609-20. PubMed ID: 16930529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface properties of rat pulmonary surfactant studied with the captive bubble method: adsorption, hysteresis, stability.
    Schürch S; Bachofen H; Goerke J; Green F
    Biochim Biophys Acta; 1992 Jan; 1103(1):127-36. PubMed ID: 1730014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased surface tension of the lung and surfactant in bleomycin-induced pulmonary fibrosis in rats.
    Horiuchi T; Ikegami M; Cherniack RM; Mason RJ
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1002-5. PubMed ID: 8887598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.